Innate Pharma announces conference call and webcast

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announces that the Company will hold a conference call on Friday, August 14, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT.

Participants during the call will be: 

• Jonathan Dickinson, Chief Executive Officer
• Yannis Morel, Executive Vice President, Chief Operating Officer
• Frédéric Lombard, Senior Vice President, Chief Financial Officer
• Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details
The live webcast will be available at the following link: 
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:  https://events.q4inc.com/analyst/322508798?pwd=Cl4ian4X

This information is also available on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website.